Celmatix is a preclinical-stage biotech company focused on ovarian health. The company aims to develop treatments for conditions caused by poor ovarian health.

Celmatix

Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Celmatix’s proprietary multi-omic ovarian health platform, the world’s largest of its kind, is the foundation of the company’s novel pipeline of first-in-class therapies. For more information visit www.celmatix.com.

Long Island Angel Network

Topspin Partners

Brainchild Holdings

Richmond Global Ventures

Evotec

Special Situations Life Sciences Innovation Fund

Despite often debilitating symptoms, such conditions are still being treated with hormonal interventions introduced more than 50 years ago. The problem doesn’t stop there. Because the ovary plays a critical role in overall endocrine function, women experience serious health problems when ovarian function fails.

Have you tuned into the latest episode of Boss Ovary? https://lnkd.in/d87q2uUN 

Don't miss this episode with our CEO + Founder Piraye Beim and Aparna (Amy) Divaraniya, PhD, CEO + Founder of Oova!

Learn more about: 
✅ Impact of outdated models: How traditional healthcare models and lack of tailored data, negatively affect women's health outcomes.

✅ Empowerment through data: The benefits of having actionable, personalized health data for women to better advocate for their own health.

✅ Innovations in healthcare: How innovations like Oova's home-based monitoring are transforming healthcare practices to be more inclusive and responsive.

Our CEO Dr. Piraye Beim recently spoke to Flow Space about Rapamycin and how researchers at Columbia University Fertility Center are looking into whether the drug can be used to slow ovarian aging. 

"There’s no data on what the consequence will be of taking a completely healthy individual and putting them on Rapamycin, suppressing their immune system chronically,” explains Beim. 

Check out the full article here:

Are you heading to the Women's Health Innovation Summit in September? Our CEO + Founder, Dr. Piraye Beim,  will be speaking on the panel "Ovarian Health: Unlocking The Future of Holistic Hormone Health" with Ivana Muncie-Vasic, CEO & Founder, Vitra Labs.

This discussion highlights the latest developments and research-to-date around ovarian function. Looking at the hormones that dominate the endocrine system, this panel assesses the broader impact that an understanding of ovarian function would have on extending fertility, delaying menopause, and significantly reducing symptoms such as sweating, heart disease and dementia experienced by women throughout their lifetime.

See you there!

A study led by researchers at  Weill Cornell Medicine show changes in the brain during menopause using PET imaging technology: https://lnkd.in/d2PBRMz3

✔ The study, led by researchers at Weill Cornell Medicine, demonstrates the use of PET imaging with an ER-binding tracer, 18F-fluoroestradiol (FES), as a novel method for tracking estrogen activity in the brain, revealing its potential to predict menopause-related cognitive and mood symptoms.

✔ PET scans reveal a significant increase in brain estrogen receptor (ER) density during menopause, with postmenopausal women showing higher ER density than premenopausal women, indicating the brain's compensatory response to declining estrogen levels.

✔ Findings suggest that elevated ER density persists up to a decade after menopause, highlighting a potentially extended window for effective estrogen therapy, which the researchers plan to further investigate for its long-term effects on brain health and symptom relief.

How much do you know about AMH? Anti-Mullerian hormone (AMH) may not be the most widely discussed or well-known hormone in reproductive health, but it is certainly important to understand for a variety of reasons.   

Learn more here and drop your comments below! We'll be doing an AMA "ask me anything" with our Founder & CEO Dr. Piraye Beim soon!  https://lnkd.in/dfd38w3m

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 31, 2024 10:57 AM	c5332c98
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 31, 2024 10:57 AM	ba91d9e0
translate crunchbase fundingrounds	general
peers	general	Aug 31, 2024 10:57 AM	26e12105
news basic	general	Aug 31, 2024 10:57 AM	52bc5b8d
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:CELMATIX

Celmatix